Article: ZOMIG(R) (zolmitriptan) Nasal Spray Provides Total Relief From All Migraine Symptoms, Study Shows.

SOMERSET, N.J., Jan. 13 /PRNewswire/ -- Results of the first study ever to assess efficacy across all symptoms commonly experienced during a migraine attack found that treatment with ZOMIG(R) (zolmitriptan) Nasal Spray produced a significantly higher rate of total symptom relief, defined as freedom from pain, nausea, and sensitivity to light and sound, at one hour after the first dose compared to placebo.(1) The study, published this month in the American Headache Society's peer-reviewed journal Headache, examined patients in a setting closely resembling normal clinical practice where patients were free to treat an attack of any baseline intensity and at any time after ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!